2024年11月，当我发布新氧青春诊所，决定从互联网医美平台转型做轻医美连锁时，外界的评价并不友 好。有人说我们越界，有人质疑我们"吃相难看"，也有人断言平台做门店不会成功。这两年，外界对新 氧的质疑与争论从未停止过。 截至目前，我们开出了第51家门店，可以说这是我们的拐点。 很多人只看到速度，却忽略了代价。重资产布局意味着报表承压，意味着阶段性亏损。如果只是做50家 店，我不会这样选择，但我的目标从一开始就是做千店连锁，所以我必须做一个"基建狂魔"。 过去两年，我们的关键词只有一个：规模。医美行业的成本结构中，营销与固定成本可以通过体量摊 薄，而真正决定长期竞争力的是供应链。随着门店数量增多、规模扩大，我们的采购数量提升，议价能 力增强，这使我们逐步建立起更稳定的供应体系，产品成本结构也开始优化。 规模带来的品牌信任与服务一致性，也在改变我们的获客方式。门店一线的数据显示，新用户中约50% 来自老用户推荐，这大大节约了我们的营销成本。 此前也有投资人问我，这套模式是否只能在一线城市跑通？为此，我系统对比了一线与非一线城市门店 的运营数据。去年下半年，无论客单价结构还是用户满意度指标，不同城市之间的差异极小。 ...

Core Insights - The company has transitioned from an internet medical beauty platform to a light medical beauty chain, opening its 51st store, marking a significant turning point despite external skepticism [2] - The focus over the past two years has been on scaling, with a strategy aimed at establishing a thousand-store chain, which has led to short-term losses due to heavy asset investment [2] - The medical beauty industry’s cost structure allows for marketing and fixed costs to be diluted through scale, while long-term competitiveness is determined by supply chain efficiency [2] Group 1 - The company has achieved a significant milestone with over 110,000 treatments performed, indicating a positive turning point alongside the opening of 51 stores [3] - Approximately 50% of new customers are acquired through referrals from existing users, significantly reducing marketing costs [3] - The operational data comparison between first-tier and non-first-tier cities shows minimal differences in customer metrics, suggesting that success depends more on standardization and cross-regional management than on geographic location [3] Group 2 - The company aims to enhance gross margins and achieve overall profitability on a quarterly basis by 2026, shifting focus from mere expansion to efficiency optimization and structural improvement [3][4] - Plans for 2026 include expanding product offerings, increasing the medical team size, and densifying the store network, alongside exploring more IP collaborations [4] - The industry is evolving from a seller's market to a buyer's market, with larger and standardized institutions gaining more bargaining power and the ability to lower consumer costs [3]

Investment Rating - The report maintains an "Overweight" rating for the industry, with a focus on new consumption sectors such as beauty care, IP derivatives, and gold jewelry [6][30]. Core Insights - The beauty care sector is seeing significant developments, including L'Oréal's minority stake investment in the Chinese skincare brand LAN and Proya's entry into the PDRN market with a new trademark [3][23]. - E-commerce company Yatsen reported a Q3 revenue of RMB 998 million, a 47.5% year-on-year increase, indicating strong growth in the beauty sector [3][23]. - The report highlights the strategic upgrades of Meili Tianyuan, focusing on brand enhancement, chain expansion, and digital transformation [3][23]. Market Performance - For the week of November 17-21, 2025, the retail, social services, and beauty care sectors experienced declines of 7.24%, 4.86%, and 4.53% respectively, ranking 28th, 15th, and 12th among 31 primary industries [15][16]. - The report notes a general downturn in consumer-focused sub-sectors, with trade, general retail, and tourism experiencing the largest declines of 9.12%, 7.49%, and 5.75% respectively [15][16]. Key Industry Events and News - L'Oréal announced a minority investment in LAN, marking its first investment in a local skincare brand in China [3][23]. - Proya launched a new product line under the "PROYA MED" brand, focusing on scientific and medical attributes [3][23]. - The report mentions significant revenue growth for companies like Yatsen and Meili Tianyuan, with Yatsen's Q3 revenue up 47.5% and Meili Tianyuan announcing strategic upgrades [3][23][24]. Investment Recommendations - The report recommends focusing on companies such as Proya, Giant Bio, Marubi, Runben, and others within the beauty care and new consumption sectors [6][30].

Core Viewpoint - The entry of the company into offline aesthetic medical clinics has led to a public rift between upstream and downstream players in the medical beauty industry, revealing long-standing grievances over interests [1] Group 1: Financial Performance - The total revenue of SOYOUNG CLINIC reached 144 million yuan, marking a year-on-year increase of 426.1%, and has become the largest revenue source for the group [2] - The company's total revenue for the second quarter was 378.7 million yuan, down 7% year-on-year, with a net loss of 36 million yuan compared to a net profit of 18.9 million yuan in the same period last year [19][20] Group 2: Market Dynamics - The company has faced accusations from numerous medical beauty institutions of being "unfaithful" and "biting the hand that feeds," particularly from its advertising clients [2] - The company’s transition from an online platform to a direct competitor in the offline space has led to a loss of trust and a phenomenon termed "de-SOYOUNGification" among partner institutions [7][8] Group 3: Strategic Decisions - The company’s management believes that self-reform is a strength rather than a weakness, despite facing resistance from some partner institutions [9] - The CEO indicated that the shift to offline operations was a long-planned strategy, initiated years ago, rather than a sudden decision [19] Group 4: Competitive Landscape - The company’s entry into the offline market has sparked direct competition with its former partners, leading to significant tensions, including a notable incident where a major client threatened to withdraw advertising spending if the new clinic opened nearby [5][6] - The company has been accused of engaging in a "price war," with significant price reductions for certain services, which has drawn criticism from upstream suppliers [17] Group 5: Business Model and Operations - The company claims that its self-operated clinics and platform services are complementary rather than competitive, with a focus on different market segments [10] - The company has implemented a separation strategy to maintain the platform's neutrality while still directing traffic to its own clinics, although this has raised questions about the integrity of its operations [14][15]

Core Viewpoint - The entry of the company into offline light medical beauty clinics has led to a public rift between upstream and downstream players in the medical beauty industry, revealing long-standing grievances over interests [2][3]. Financial Performance - The total revenue of SOYOUNG CLINIC reached 144 million yuan, marking a year-on-year increase of 426.1%, and has become the largest revenue source for the group [2][12]. - The company's total revenue for the second quarter was 378.7 million yuan, down 7% year-on-year, with a net loss of 36 million yuan compared to a net profit of 18.9 million yuan in the same period last year [12]. Business Strategy - The company has launched its self-operated light medical beauty chain, SOYOUNG CLINIC, with plans to expand from 33 stores to 50 by the end of 2025 [2][3]. - The management believes that self-revolution is a strength, despite facing resistance from some partner institutions [2][6]. Industry Dynamics - The transition from an online platform to a direct competitor has caused trust issues with former partners, leading to a trend of "de-SOYOUNG-ization" among medical beauty institutions [5][6]. - The company has faced accusations of "eating from both sides" by competing with its own partners, which has resulted in some partners withdrawing from collaboration [5][11]. Market Competition - The opening of new clinics has sparked conflicts with existing partners, including a major client that threatened to withdraw advertising spending if the new clinic opened nearby [4][5]. - The company has initiated a price war, offering services at significantly lower prices than competitors, which has drawn criticism from upstream suppliers [11]. Operational Insights - The company claims that its self-operated clinics and platform services are complementary rather than competitive, focusing on different market segments [6][12]. - Despite claims of separation, there are indications that the platform may still direct traffic to its own clinics, raising questions about the integrity of its operations [8][9].

Core Insights - New Oxygen reported a total revenue of 379 million yuan for Q2 2025, with chain business revenue reaching 144 million yuan, marking a significant expansion in its offline medical beauty chain [1] - The company experienced a net loss of 36.039 million yuan in Q2, with a Non-GAAP net loss of 30.544 million yuan, attributed to the rapid expansion and ongoing investments in its chain business [1] - CEO Jin Xing announced that the offline chain business became the largest revenue source for the company in Q2 2024, indicating a critical transition from an online medical beauty platform to a vertically integrated "online + offline" model [1] Financial Performance - The chain business has shown a positive cash flow in most stores, and the company has maintained a steady opening pace without aggressive spending strategies [2] - The overall profitability of the platform and upstream business supports the investments in the chain business, with expectations for a shorter turnaround period to profitability as competition drives down upstream product prices [2] Business Strategy - New Oxygen is addressing service quality control challenges in its chain expansion by implementing a differentiated solution that standardizes the "diagnosis + treatment" process [2] - The company aims to reduce customer acquisition costs and improve service quality-to-price ratio, addressing the industry's trust crisis and pushing for a higher penetration rate in the medical beauty market [2] - New Oxygen's pricing strategy is not aimed at starting a price war but rather at bringing medical beauty prices back to reasonable levels, as current prices in China are significantly higher than in countries like South Korea [2]

Core Viewpoint - The company, Xinyang (SY.US), experienced a significant stock increase of 9.43%, closing at $4.06, with a total market capitalization of $403 million. The Q2 2025 financial report indicates robust growth in the company's revenue, particularly in its offline light medical beauty segment, which has become the largest revenue source for the company [1]. Financial Performance - In Q2 2025, the company achieved total revenue of 379 million yuan [1]. - The revenue from medical beauty treatment services reached 144 million yuan, reflecting a year-on-year growth rate of 426.1% [1]. Business Expansion - The number of medical beauty clinics under the light medical beauty chain brand "Xinyang Youth Clinic" has increased to 33 [1]. - The company's Chairman and CEO, Jin Xing, stated that there will be an increased density of Xinyang Youth Clinics in major cities such as Beijing and Guangzhou, with an expectation to reach 50 clinics by the end of the year [1].

Core Viewpoint - New Oxygen Technology is undergoing a significant strategic transformation amid a slowdown in online traffic and increasing regulation in the medical beauty industry, with a notable shift from online services to offline light medical beauty chain operations [1][2]. Financial Performance - In Q2, New Oxygen reported total revenue of 379 million yuan, a year-on-year decline of 7.0% [3]. - The company experienced a net loss of 36 million yuan in Q2, compared to a profit of 18.9 million yuan in the same period last year [4]. - Revenue from information and appointment services, a core business, fell by 35.6% to 135 million yuan, indicating intensified competition and regulatory pressures [3][4]. Business Transition - New Oxygen's offline light medical beauty chain business saw a remarkable growth of 426.1% in revenue, reaching 144 million yuan, becoming the largest revenue source for the company [1][6]. - The company plans to expand its "New Oxygen Youth Clinic" brand across China, aiming for a thousand-store scale in 8 to 10 years [6][7]. Operational Strategy - The management emphasizes a self-operated model for new stores, which allows for controlled capital expenditure and shorter payback periods, supported by a cash reserve of 999 million yuan [8]. - A franchise model is also being considered, with plans to pilot 2 to 3 franchise stores later this year [9]. Market Outlook - The rapid growth of the light medical beauty market is attracting more participants, leading to increased competition, which poses ongoing challenges for New Oxygen [9].

Core Viewpoint - New Oxygen Technology is undergoing a significant strategic transformation amid a slowdown in online traffic and increasing regulation in the medical beauty industry, with a notable shift from online services to offline light medical beauty chain operations [1][2]. Financial Performance - In Q2, New Oxygen reported total revenue of 379 million yuan, a year-on-year decline of 7.0% [3]. - The company experienced a net loss of 36 million yuan in Q2, compared to a profit of 18.9 million yuan in the same period last year [4]. - Revenue from information and appointment services, a core business, fell by 35.6% to 135 million yuan, indicating intensified competition and regulatory pressures [3][4]. Business Transformation - New Oxygen's offline light medical beauty chain business saw a dramatic increase, with revenue soaring by 426.1% to 144 million yuan, becoming the largest revenue source for the company [1][5]. - The company aims to expand its "New Oxygen Youth Clinic" brand across major cities, with plans to increase the number of medical centers to 50 by the end of 2025 [6][7]. Market Position and Strategy - The management emphasizes the importance of standardization and product innovation to maintain market leadership in the light medical beauty sector [5]. - New Oxygen plans to adopt a mixed model of self-operated and franchised stores, with pilot franchise stores expected to launch in Q4 [7]. Future Outlook - The company has set a long-term goal of achieving a thousand-store scale within 8 to 10 years, reflecting confidence in the growth potential of the light medical beauty market [6][7]. - Despite the positive developments, New Oxygen faces challenges from increasing competition as more players enter the light medical beauty market [8].

Core Viewpoint - New Oxygen aims to become a disruptor in the medical beauty industry by launching its own light medical beauty brand, "New Oxygen Youth Clinic," to create a "high quality, low price" model in response to the changing consumer demographics and market dynamics [1][2][3] Company Strategy - New Oxygen has transitioned from being a medical beauty e-commerce platform to establishing its own light medical beauty clinics, targeting a broader consumer base beyond high-net-worth individuals [2][3] - The company plans to integrate and optimize its supply chain to lower costs and enhance service quality, addressing consumer pain points related to high prices and inconsistent treatment quality [3][8] Market Dynamics - The light medical beauty market in China reached a scale of 1,461 billion yuan in 2023, accounting for 80.8% of total medical beauty consumption, with a year-on-year growth of 5.8% [7] - The market is expected to grow to 4,157 billion yuan by 2030, nearly double that of surgical medical beauty [7] Financial Performance - New Oxygen's light medical beauty chain business reported a revenue increase of 551.4% year-on-year to 98.88 million yuan in Q1 2025, contributing 33.3% to total revenue [3] - The company anticipates its medical treatment service revenue to reach 120-140 million yuan in Q2 2024, representing a year-on-year growth of 337%-410% [3] Competitive Landscape - New Oxygen's pricing strategy has led to friction with upstream manufacturers over pricing authority, highlighting a shift in market dynamics where pricing should be determined by supply and demand rather than manufacturer control [5][6] - The company has made strategic acquisitions to strengthen its position in the upstream medical beauty market, including a significant investment in a medical device company [7][8] Industry Challenges - The medical beauty industry faces challenges such as declining profits and increasing scrutiny from regulators, necessitating a transformation in business models and practices [3][11] - New Oxygen aims to address safety and quality concerns in the industry by ensuring rigorous training for its medical staff and maintaining high operational standards [10][12] Future Outlook - The industry is expected to evolve towards a model where professional doctors operate clinics, ensuring safety and quality, alongside large chain institutions like New Oxygen Youth Clinic [11][13] - The company envisions a future where transparent pricing and service quality will become the norm, making light medical beauty accessible to a wider audience [12][13]